Berry Global (BERY) 10-Q 3 Aug 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Millions	9 Months Ended
	Jun. 30, 2018	Aug. 03, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	BERRY GLOBAL GROUP INC
Entity Central Index Key	1,378,992
Current Fiscal Year End Date	--09-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		131.8
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Consolidated Statements of Income (Unaudited) [Abstract]
Net sales	$ 2,072	$ 1,906	$ 5,815	$ 5,214
Costs and expenses:
Cost of goods sold	1,690	1,518	4,733	4,177
Selling, general and administrative	119	128	366	373
Amortization of intangibles	40	40	116	113
Restructuring and impairment charges	7	8	33	18
Operating income	216	212	567	533
Other expense (income), net	3	(1)	17	18
Interest expense, net	67	68	195	203
Income before income taxes	146	145	355	312
Income tax expense (benefit)	36	38	(8)	82
Net income	$ 110	$ 107	$ 363	$ 230
Net income per share:
Basic (in dollars per share)	$ 0.84	$ 0.82	$ 2.76	$ 1.82
Diluted (in dollars per share)	$ 0.81	$ 0.79	$ 2.67	$ 1.75
Outstanding weighted-average shares:
Basic (in shares)	131.7	129.9	131.3	126.6
Diluted (in shares)	135.4	135.2	135.8	131.4

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 110	$ 107	$ 363	$ 230
Currency translation	(92)	24	(109)	4
Pension and other postretirement benefits	0	0	(1)	13
Interest rate hedges	6	(1)	47	23
Provision for income taxes	(2)	0	(13)	(8)
Other comprehensive income (loss), net of tax	(88)	23	(76)	32
Comprehensive income	$ 22	$ 130	$ 287	$ 262

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Current assets:
Cash and cash equivalents	$ 365	$ 306
Accounts receivable (less allowance of $13)	932	847
Inventories:
Finished goods	557	428
Raw materials and supplies	398	334
Inventories	955	762
Prepaid expenses and other current assets	85	89
Total current assets	2,337	2,004
Property, plant, and equipment, net	2,507	2,366
Goodwill and intangible assets, net	4,157	4,061
Other assets	41	45
Total assets	9,042	8,476
Current liabilities:
Accounts payable	726	638
Accrued expenses and other current liabilities	401	463
Current portion of long-term debt	35	33
Total current liabilities	1,162	1,134
Long-term debt, less current portion	5,910	5,608
Deferred income taxes	334	419
Other long-term liabilities	297	300
Total liabilities	7,703	7,461
Stockholders' equity
Common stock (131.8 and 130.9 million shares issued, respectively)	1	1
Additional paid-in capital	860	823
Non-controlling interest	3	3
Retained earnings	619	256
Accumulated other comprehensive loss	(144)	(68)
Total stockholders' equity	1,339	1,015
Total liabilities and stockholders' equity	$ 9,042	$ 8,476

Consolidated Balance Sheets (U5

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Millions, $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Current assets:
Accounts receivable, allowance	$ 13	$ 13
Stockholders' equity
Common stock, shares issued (in shares)	131.8	130.9

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017
Cash Flows from Operating Activities:
Net income	$ 363	$ 230
Adjustments to reconcile net cash provided by operating activities:
Depreciation	281	270
Amortization of intangibles	116	113
Non-cash interest expense	6	6
Settlement of interest rate hedges	30	0
Deferred income tax	(71)	39
Stock compensation expense	20	16
Other non-cash operating activities, net	15	26
Changes in working capital	(240)	(113)
Changes in other assets and liabilities	36	(7)
Net cash from operating activities	556	580
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(270)	(201)
Proceeds from sale of assets	3	4
Acquisition of business, net of cash acquired	(474)	(515)
Other investing activities, net	0	(1)
Net cash from investing activities	(741)	(713)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings	497	545
Repayments on long-term borrowings	(224)	(427)
Proceeds from issuance of common stock	17	26
Payment of tax receivable agreement	(37)	(60)
Debt financing costs	(1)	(4)
Net cash from financing activities	252	80
Effect of exchange rate changes on cash	(8)	5
Net change in cash	59	(48)
Cash and cash equivalents at beginning of period	306	323
Cash and cash equivalents at end of period	$ 365	$ 275

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jun. 30, 2018
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. Certain reclassifications have been made to prior periods to conform to current reporting. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
	Jun. 30, 2018
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements	2. Recently Issued Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification. During fiscal 2018, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2017 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements. Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company has evaluated a substantial portion of its contracts with key customers and is evaluating the provisions under the five-step model specified by the new standard. While the Company continues to evaluate the potential impacts of the new standard, based on procedures to date we do not expect a material impact to the consolidated financial statements. Adoption of the new standard will result in expanded revenue disclosures. The Company plans to adopt the new standard which will be effective for the Company beginning in fiscal 2019 using the modified retrospective approach. Hedges In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities in order to more closely align the results of hedge accounting with risk management activities through changes to the designation and measurement guidance. The new standard is effective for interim and annual periods beginning after December 15, 2018. The effect of adoption should be reflected on all active hedges as of the beginning of the fiscal year of adoption. The Company has chosen to early adopt this standard for fiscal 2018, and the adoption of this standard did not have a material impact on the consolidated financial statements. Comprehensive Income In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income. The new standard allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The new standard is effective for interim and annual periods beginning after December 15, 2018. The Company is currently evaluating the impact of this standard.

Acquisitions

Acquisitions	9 Months Ended
	Jun. 30, 2018
Acquisitions [Abstract]
Acquisitions	3. Acquisitions AEP Industries Inc. In January 2017, the Company acquired AEP Industries Inc. ("AEP") for a purchase price of $791 million, net of cash acquired. A portion of the purchase price consisted of issuing 6.4 million of Berry common shares which were valued at $324 million at the time of closing. AEP manufactures and markets an extensive and diverse line of polyethylene and polyvinyl chloride flexible plastic packaging products for consumer, industrial, and agricultural applications. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $500 million due 2024. Unaudited pro forma net sales were $5.5 billion for the three quarterly periods ended July 1, 2017. The unaudited pro forma net income was $232 million for the three quarterly periods ended July 1, 2017. The unaudited pro forma net sales and net income assume that the AEP acquisition had occurred at the beginning of the period. Adchem Corp. In June 2017, the Company acquired Adchem Corp.'s ("Adchem") tapes business for a purchase price of $49 million, which the Company financed using existing liquidity. Adchem is a leader in the development of high performance adhesive tape systems for the automotive, construction, electronics, graphic arts, medical and general tape markets. The acquired business is operated in our Engineered Materials segment. Clopay Plastic Products Company, Inc. In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $474 million, which is preliminary and subject to adjustment. Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel. The acquired business is operated within our Health, Hygiene & Specialties segment. To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering. The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary fair values at the acquisition date. The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition. The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed. The Company has recognized Goodwill on this transaction primarily as a result of expected cost synergies, and expects Goodwill to be deductible for tax purposes. The following table summarizes the preliminary purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition: Working capital (a) $ 70 Property and equipment 164 Intangible assets 118 Goodwill 123 Other assets and long-term liabilities (1 ) (a) Includes a $3 million step up of inventory to fair value

Accounts Receivable Factoring A

Accounts Receivable Factoring Agreements	9 Months Ended
	Jun. 30, 2018
Accounts Receivable Factoring Agreements [Abstract]
Accounts Receivable Factoring Agreements	4. Accounts Receivable Factoring Agreements The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. There were no amounts outstanding from financial institutions related to U.S. based programs at June 30, 2018 or September 30, 2017. Gross amounts factored under these U.S. based programs at June 30, 2018 and September 30, 2017 were $108 million and $129 million, respectively. The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

Restructuring and Impairment Ch

Restructuring and Impairment Charges	9 Months Ended
	Jun. 30, 2018
Restructuring and Impairment Charges [Abstract]
Restructuring and Impairment Charges	5. Restructuring and Impairment Charges The Company incurred restructuring costs related to severance charges associated with acquisition integrations and facility exit costs. The tables below set forth the significant components of the restructuring charges recognized, by segment: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Engineered Materials $ 2 $ 2 $ 4 $ 4 Health, Hygiene & Specialties 4 4 26 8 Consumer Packaging 1 2 3 6 Consolidated $ 7 $ 8 $ 33 $ 18 The table below sets forth the activity with respect to the restructuring accrual at June 30, 2018: Employee Severance and Benefits Facility Exit Costs Total Balance at September 30, 2017 $ 14 $ 5 $ 19 Charges 31 2 33 Cash payments (30 ) (3 ) (33 ) Balance at June 30, 2018 $ 15 $ 4 $ 19

Accrued Expenses, Other Current

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities	9 Months Ended
	Jun. 30, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities	6. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets: June 30, 2018 September 30, 2017 Employee compensation $ 109 $ 147 Accrued taxes 73 90 Rebates 54 58 Interest 38 36 Tax receivable agreement obligation 24 35 Restructuring 19 19 Accrued operating expenses 84 78 $ 401 $ 463 The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets: June 30, 2018 September 30, 2017 Pension liability $ 53 $ 56 Lease retirement obligation 43 37 Deferred purchase price 41 46 Transition tax 36 — Sale-lease back deferred gain 22 24 Derivative instruments 16 27 Tax receivable agreement obligation 13 34 Other 73 76 $ 297 $ 300

Long-Term Debt

Long-Term Debt	9 Months Ended
	Jun. 30, 2018
Long-Term Debt [Abstract]
Long-Term Debt	7. Long-Term Debt Long-term debt consists of the following: Maturity Date June 30, 2018 September 30, 2017 Term loan February 2020 $ 800 $ 1,000 Term loan January 2021 814 814 Term loan October 2022 1,645 1,645 Term loan January 2024 494 498 Revolving line of credit May 2020 — — 5 1 / 2 May 2022 500 500 6% Second Priority Senior Secured Notes October 2022 400 400 5 1 / 8 July 2023 700 700 4 1 / 2 February 2026 500 — Debt discounts and deferred fees (46 ) (48 ) Capital leases and other Various 138 132 Total long-term debt 5,945 5,641 Current portion of long-term debt (35 ) (33 ) Long-term debt, less current portion $ 5,910 $ 5,608 The Company was in compliance with all debt covenants for all periods presented. Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity. 4 1 / 2 In January 2018, the Company issued $500 million aggregate principal amount of 4.50% second priority senior secured notes due 2026. Interest on these notes is due semiannually in February and August. The Company recognized $4 million of debt discount related to this offering. The net proceeds were used to fund the Clopay acquisition. Term Loans In November 2017, February 2018, and May 2018, the Company executed agreements to reduce interest rates under certain term loans. The term loans with a maturity date of February 2020 and January 2021 bear interest at LIBOR plus 1.75%. The term loans with a maturity date of October 2022 and January 2024 bear interest at LIBOR plus 2.00%. During fiscal 2018, the Company has made $224 million of repayments on long-term borrowings using existing liquidity.

Financial Instruments and Fair

Financial Instruments and Fair Value Measurements	9 Months Ended
	Jun. 30, 2018
Financial Instruments and Fair Value Measurements [Abstract]
Financial Instruments and Fair Value Measurements	8. Financial Instruments and Fair Value Measurements In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income. Cross-Currency Swaps In November 2017, the Company entered into certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt. The swap agreements mature in May 2022. The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company's term loans. Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged. Interest Rate Swaps The primary purpose of the Company's interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt. In February 2013, the Company entered into a $1 billion interest rate swap transaction with an effective date of May 2016 and expiration in May 2019. In June 2013, the Company elected to settle this derivative instrument and received $16 million as a result of this settlement. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the original term of the swap agreement. During fiscal 2017 the Company modified various term loan rates and maturities. In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps. In June 2018, the Company elected to settle two of its derivative instruments with expiration dates in June 2019 and September 2021, and received $9 million and $21 million, respectively. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the original expiration dates for of each of the swap agreements. The Company also entered into a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date of June 2018 and expiration in September 2021. At June 30, 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021. The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. When valuing swaps the Company utilizes Level 2 inputs (substantially observable). Balances on a gross basis as of the current period are as follows: Derivative Instruments Hedge Designation Balance Sheet Location June 30, 2018 September 30, 2017 Cross-currency swaps Designated Other long-term liabilities $ 10 $ — Interest rate swaps Designated Other assets 12 1 Interest rate swaps Not designated Other assets 1 13 Interest rate swaps Designated Other long-term liabilities 4 15 Interest rate swaps Not designated Other long-term liabilities 2 13 The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Three Quarterly Periods Ended Derivative Instruments Statements of Income Location June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Cross-currency swaps Interest expense, net $ (2 ) $ — $ (4 ) $ — Foreign currency swaps Other expense, net — 1 — — Interest rate swaps Interest expense, net (1 ) 5 2 15 The amortization related to unrealized Interest rate swap interest income within Accumulated other comprehensive loss is expected to be $13 million in the next 12 months. Non-recurring Fair Value Measurements The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present. The assets are adjusted to fair value only when the carrying values exceed the fair values. The categorization of the framework used to price the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets include primarily our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant, and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year, and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2017 assessment. However, as a result of the existence of impairment indicators in our Health, Hygiene & Specialties - South America ("HHS-SA") reporting unit during the quarter, we concluded that an interim impairment test was necessary. The reporting unit's fair value is estimated based on a market approach and a discounted cash flow analysis and is reconciled back to the current market capitalization for Berry Global Group, Inc. to ensure that the implied control premium is reasonable. Our forecasts assumed overall revenue growth of 2% increasing to 4% in the terminal year, margins consistent with historical results, a discount rate of 14% applied to the forecasted cash flows, and capital expenditure levels consistent with historical spend. The fair value of the HHS-SA reporting unit exceeded its carrying value by 5%. However, future declines in valuation market multiples, sustained lower earnings, or macroeconomic challenges could impact future impairment tests. The goodwill balance for the HHS-SA reporting unit as of June 30, 2018 was $92 million. Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of June 30, 2018 and September 30, 2017, along with the impairment loss recognized on the fair value measurement during the period: As of June 30, 2018 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 2,880 2,880 — Definite lived intangible assets — — 1,029 1,029 — Property, plant, and equipment — — 2,507 2,507 — Total $ — $ — $ 6,664 $ 6,664 $ — As of September 30, 2017 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 2,775 2,775 — Definite lived intangible assets — — 1,038 1,038 — Property, plant, and equipment — — 2,366 2,366 2 Total $ — $ — $ 6,427 $ 6,427 $ 2 The Company's financial instruments consist primarily of cash and cash equivalents and long-term debt. The book value of our marketable long-term indebtedness exceeded fair value by $22 million as of June 30, 2018. The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

Income Taxes

Income Taxes	9 Months Ended
	Jun. 30, 2018
Income Taxes [Abstract]
Income Taxes	9. Income Taxes In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates. As the Company has a September fiscal year-end, the lower corporate income tax rate will be phased in during fiscal 2018 and will be 21% in subsequent years. Partially offsetting the lower corporate income tax, the Tax Act also eliminates certain domestic deductions that were previously included in our estimated annual tax rate. As part of the transition to the new tax system, the Tax Act (i) imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries and (ii) requires the Company revalue our U.S. net deferred tax liability position to the lower federal base rate of 21%. These transitional impacts resulted in a provisional transition benefit of $95 million for the first fiscal quarter, comprised of an estimated repatriation tax charge of $44 million (comprised of the U.S. repatriation taxes and foreign withholding taxes) and an estimated net deferred tax revaluation benefit of $139 million. The estimated impact of the corporate income tax net reduction along with the transitional taxes were recorded to the Consolidated Statements of Income in the Company's first fiscal quarter. The changes included in the Tax Act are broad and complex. The final transition impacts of the Tax Act may differ from the above estimate, possibly materially, due to, among other things, changes in interpretations of the Tax Act, any legislative action to address questions that arise because of the Tax Act, any changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or any updates or changes to estimates the Company has utilized to calculate the transition impacts. The Securities and Exchange Commission has issued guidance that would allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. We currently anticipate finalizing and recording any resulting adjustments by the end of fiscal 2018. The effective tax rate was 25% for the Quarter and was positively impacted by 1% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and a 2% benefit from the domestic manufacturing deduction. These favorable items were partially offset by increases of 3% from U.S. state income taxes, 2% from foreign valuation allowance, and other discrete items.

Operating Segments

Operating Segments	9 Months Ended
	Jun. 30, 2018
Operating Segments [Abstract]
Operating Segments	10. Operating Segments The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging. The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner. Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: Engineered Materials $ 687 $ 686 $ 1,990 $ 1,689 Health, Hygiene & Specialties 726 606 2,009 1,773 Consumer Packaging 659 614 1,816 1,752 Total net sales $ 2,072 $ 1,906 $ 5,815 $ 5,214 Operating income: Engineered Materials $ 94 $ 99 $ 276 $ 219 Health, Hygiene & Specialties 62 53 140 164 Consumer Packaging 60 60 151 150 Total operating income $ 216 $ 212 $ 567 $ 533 Depreciation and amortization: Engineered Materials $ 26 $ 30 $ 82 $ 73 Health, Hygiene & Specialties 51 46 146 136 Consumer Packaging 59 56 169 174 Total depreciation and amortization $ 136 $ 132 $ 397 $ 383 June 30, 2018 September 30, 2017 Total assets: Engineered Materials $ 1,795 $ 1,803 Health, Hygiene & Specialties 3,963 3,496 Consumer Packaging 3,284 3,177 Total assets $ 9,042 $ 8,476 Total goodwill: Engineered Materials $ 550 $ 545 Health, Hygiene & Specialties 921 819 Consumer Packaging 1,409 1,411 Total goodwill $ 2,880 $ 2,775 Selected information by geographical region is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: North America $ 1,636 $ 1,591 $ 4,703 $ 4,289 South America 193 85 347 246 Europe 181 165 577 482 Asia 62 65 188 197 Total net sales $ 2,072 $ 1,906 $ 5,815 $ 5,214 June 30, 2018 September 30, 2017 Long-lived assets: North America $ 5,598 $ 5,350 South America 343 371 Europe 459 467 Asia 305 284 Total Long-lived assets $ 6,705 $ 6,472 Selected information by product line is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended (in percentages) June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: Performance Materials 46 % 46 % 46 % 46 % Engineered Products 54 54 54 54 Engineered Materials 100 % 100 % 100 % 100 % Health 16 % 22 % 17 % 22 % Hygiene 52 44 48 44 Specialties 32 34 35 34 Health, Hygiene & Specialties 100 % 100 % 100 % 100 % Rigid Open Top 45 % 44 % 43 % 42 % Rigid Closed Top 55 56 57 58 Consumer Packaging 100 % 100 % 100 % 100 %

Contingencies and Commitments

Contingencies and Commitments	9 Months Ended
	Jun. 30, 2018
Contingencies and Commitments [Abstract]
Contingencies and Commitments	11. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Basic and Diluted Net Income Pe

Basic and Diluted Net Income Per Share	9 Months Ended
	Jun. 30, 2018
Basic and Diluted Net Income Per Share [Abstract]
Basic and Diluted Net Income Per Share	12. Basic and Diluted Net Income Per Share Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. There were no shares excluded from the calculations as the effect of their conversion into shares of our common stock would be antidilutive. The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations. Quarterly Period Ended Three Quarterly Periods Ended (in millions, except per share amounts) June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Numerator Net income $ 110 $ 107 $ 363 $ 230 Denominator Weighted average common shares outstanding - basic 131.7 129.9 131.3 126.6 Dilutive shares 3.7 5.3 4.5 4.8 Weighted average common and common equivalent shares outstanding - diluted 135.4 135.2 135.8 131.4 Per common share income Basic $ 0.84 $ 0.82 $ 2.76 $ 1.82 Diluted $ 0.81 $ 0.79 $ 2.67 $ 1.75

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jun. 30, 2018
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	13. Accumulated Other Comprehensive Loss The components and activity of Accumulated other comprehensive loss are as follows: Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Interest Rate Swaps Accumulated Other Comprehensive Loss Balance at September 30, 2017 $ (48 ) $ (16 ) $ (4 ) $ (68 ) Other comprehensive income (loss) before reclassifications (109 ) (1 ) 42 (68 ) Net amount reclassified from accumulated other comprehensive income (loss) — — 5 5 Provision for income taxes — — (13 ) (13 ) Balance at June 30, 2018 $ (157 ) $ (17 ) $ 30 $ (144 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Interest Rate Swaps Accumulated Other Comprehensive Loss Balance at October 1, 2016 $ (82 ) $ (44 ) $ (22 ) $ (148 ) Other comprehensive income (loss) before reclassifications 4 13 5 22 Net amount reclassified from accumulated other comprehensive income (loss) — — 18 18 Provision for income taxes — — (8 ) (8 ) Balance at July 1, 2017 $ (78 ) $ (31 ) $ (7 ) $ (116 )

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	9 Months Ended
	Jun. 30, 2018
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	14. Guarantor and Non-Guarantor Financial Information Berry Global, Inc. ("Issuer") has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, "Parent") and substantially all of Issuer's domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company's debts. Parent also guarantees the Issuer's term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility. Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries. The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer's indentures. The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements. The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries. All consolidating entries are included in the eliminations column along with the elimination of intercompany balances. Condensed Supplemental Consolidated Balance Sheet June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Current assets $ — $ 311 $ 1,270 $ 756 $ — $ 2,337 Intercompany receivable 332 2,101 — — (2,433 ) — Property, plant, and equipment, net — 79 1,688 740 — 2,507 Other assets 1,378 5,995 4,713 497 (8,385 ) 4,198 Total assets $ 1,710 $ 8,486 $ 7,671 $ 1,993 $ (10,818 ) $ 9,042 Current liabilities $ 24 $ 253 $ 580 $ 305 $ — $ 1,162 Intercompany payable — — 2,373 60 (2,433 ) — Other long-term liabilities 347 6,049 85 60 — 6,541 Stockholders' equity 1,339 2,184 4,633 1,568 (8,385 ) 1,339 Total liabilities and stockholders' equity $ 1,710 $ 8,486 $ 7,671 $ 1,993 $ (10,818 ) $ 9,042 September 30, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Current assets $ — $ 116 $ 1,113 $ 775 $ — $ 2,004 Intercompany receivable 512 2,217 — — (2,729 ) — Property, plant and equipment, net — 80 1,564 722 — 2,366 Other assets 992 5,335 4,583 533 (7,337 ) 4,106 Total assets $ 1,504 $ 7,748 $ 7,260 $ 2,030 $ (10,066 ) $ 8,476 Current liabilities $ 36 $ 243 $ 537 $ 318 $ — $ 1,134 Intercompany payable — — 2,667 62 (2,729 ) — Other long-term liabilities 453 5,707 99 68 — 6,327 Stockholders' equity 1,015 1,798 3,957 1,582 (7,337 ) 1,015 Total liabilities and stockholders' equity $ 1,504 $ 7,748 $ 7,260 $ 2,030 $ (10,066 ) $ 8,476 Condensed Supplemental Consolidated Statements of Income Quarterly Period Ended June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 147 $ 1,452 $ 473 $ — $ 2,072 Cost of goods sold — 121 1,173 396 — 1,690 Selling, general and administrative — 14 70 35 — 119 Amortization of intangibles — — 34 6 — 40 Restructuring and impairment charges — — 4 3 — 7 Operating income — 12 171 33 — 216 Other expense (income), net — — 1 2 — 3 Interest expense, net — 5 46 16 — 67 Equity in net income of subsidiaries (146 ) (128 ) — — 274 — Income before income taxes 146 135 124 15 (274 ) 146 Income tax expense 36 25 3 8 (36 ) 36 Net income $ 110 $ 110 $ 121 $ 7 $ (238 ) $ 110 Comprehensive net income $ 110 $ 133 $ 121 $ (104 ) $ (238 ) $ 22 Quarterly Period Ended July 1, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 152 $ 1,325 $ 429 $ — $ 1,906 Cost of goods sold — 100 1,059 359 — 1,518 Selling, general and administrative — 14 89 25 — 128 Amortization of intangibles — 2 31 7 — 40 Restructuring and impairment charges — — - 8 — 8 Operating income — 36 146 30 — 212 Other expense (income), net — 1 (1 ) (1 ) — (1 ) Interest expense, net — 5 47 16 — 68 Equity in net income of subsidiaries (145 ) (109 ) — — 254 — Income before income taxes 145 139 100 15 (254 ) 145 Income tax expense 38 32 — 6 (38 ) 38 Net income $ 107 $ 107 $ 100 $ 9 $ (216 ) $ 107 Comprehensive net income $ 107 $ 102 $ 100 $ 37 $ (216 ) $ 130 Three Quarterly Periods Ended June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 424 $ 4,026 $ 1,365 $ — $ 5,815 Cost of goods sold — 322 3,265 1,146 — 4,733 Selling, general and administrative — 44 233 89 — 366 Amortization of intangibles — — 96 20 — 116 Restructuring and impairment charges — — 20 13 — 33 Operating income — 58 412 97 — 567 Other expense (income), net — 5 8 4 — 17 Interest expense, net — 14 134 47 — 195 Equity in net income of subsidiaries (355 ) (287 ) — — 642 — Income before income taxes 355 326 270 46 (642 ) 355 Income tax expense (8 ) (37 ) 4 25 8 (8 ) Net income $ 363 $ 363 $ 266 $ 21 $ (650 ) $ 363 Comprehensive net income $ 363 $ 387 $ 266 $ (79 ) $ (650 ) $ 287 Consolidating Statement of Cash Flows Cash Flow from Operating Activities $ — $ 29 $ 480 $ 47 $ — $ 556 Cash Flow from Investing Activities Additions to property, plant, and equipment — (5 ) (194 ) (71 ) — (270 ) Proceeds from sale of assets — — — 3 — 3 Contributions (to)/from subsidiaries (17 ) (457 ) — — 474 — Intercompany — 314 — — (314 ) — Acquisition of business, net of cash acquired — — (404 ) (70 ) — (474 ) Other investing activities, net — — — — — — Net cash from investing activities (17 ) (148 ) (598 ) (138 ) 160 (741 ) Cash Flow from Financing Activities Proceeds from long-term debt — 497 — — — 497 Repayments on long-term borrowings — (219 ) (5 ) — — (224 ) Proceeds from issuance of common stock 17 — — — — 17 Payment of tax receivable agreement (37 ) — — — — (37 ) Contribution from Parent — — 404 70 (474 ) — Debt financing costs — (1 ) — — — (1 ) Changes in intercompany balances 37 — (291 ) (60 ) 314 — Net cash from financing activities 17 277 108 10 (160 ) 252 Effect of exchange rate changes on cash — — — (8 ) — (8 ) Net change in cash — 158 (10 ) (89 ) — 59 Cash and cash equivalents at beginning of period — 18 12 276 — 306 Cash and cash equivalents at end of period $ — $ 176 $ 2 $ 187 $ — $ 365 Three Quarterly Periods Ended July 1, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 441 $ 3,556 $ 1,217 $ — $ 5,214 Cost of goods sold — 333 2,860 984 — 4,177 Selling, general and administrative — 45 251 77 — 373 Amortization of intangibles — 5 87 21 — 113 Restructuring and impairment charges — — 10 8 — 18 Operating income — 58 348 127 — 533 Other expense (income), net — 15 1 2 — 18 Interest expense, net — 17 138 48 — 203 Equity in net income of subsidiaries (312 ) (252 ) — — 564 — Income before income taxes 312 278 209 77 (564 ) 312 Income tax expense 82 48 — 34 (82 ) 82 Net income $ 230 $ 230 $ 209 $ 43 $ (482 ) $ 230 Comprehensive net income $ 230 $ 245 $ 209 $ 60 $ (482 ) $ 262 Consolidating Statement of Cash Flows Cash Flow from Operating Activities $ — $ 31 $ 420 $ 129 $ — $ 580 Cash Flow from Investing Activities Additions to property, plant, and equipment — (11 ) (160 ) (30 ) — (201 ) Proceeds from sale of assets — 1 3 — — 4 Contributions (to)/from subsidiaries (26 ) (489 ) — — 515 — Intercompany — 280 — — (280 ) — Acquisition of business, net of cash acquired — — (515 ) — — (515 ) Other investing activities, net — (1 ) — — — (1 ) Net cash from investing activities (26 ) (220 ) (672 ) (30 ) 235 (713 ) Cash Flow from Financing Activities Proceeds from long-term debt — 545 — — — 545 Repayments on long-term borrowings — (423 ) (3 ) (1 ) — (427 ) Proceeds from issuance of common stock 26 — — — — 26 Payment of tax receivable agreement (60 ) — — — — (60 ) Debt financing costs — (4 ) — — — (4 ) Contribution from parent — — 515 — (515 ) — Changes in intercompany balances 60 — (255 ) (85 ) 280 — Net cash from financing activities 26 118 257 (86 ) (235 ) 80 Effect of exchange rate changes on cash — — — 5 — 5 Net change in cash — (71 ) 5 18 — (48 ) Cash and cash equivalents at beginning of period — 102 5 216 — 323 Cash and cash equivalents at end of period $ — $ 31 $ 10 $ 234 $ — $ 275

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	15. Subsequent Events In August 2018, the Company announced that its Board has authorized a $500 million share repurchase program. Share repurchases, if any, will be made through open market purchases, privately negotiated transactions, Rule 10b5-1 plans, or other transactions in accordance with applicable securities laws and in such amounts at such times as we deem appropriate based upon prevailing market and business conditions and other factors. The share repurchase program has no expiration date and may be suspended at any time.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jun. 30, 2018
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.
Reclassifications	Certain reclassifications have been made to prior periods to conform to current reporting.

Recently Issued Accounting Pr23

Recently Issued Accounting Pronouncements (Policies)	9 Months Ended
	Jun. 30, 2018
Recently Issued Accounting Pronouncements [Abstract]
Revenue Recognition	Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company has evaluated a substantial portion of its contracts with key customers and is evaluating the provisions under the five-step model specified by the new standard. While the Company continues to evaluate the potential impacts of the new standard, based on procedures to date we do not expect a material impact to the consolidated financial statements. Adoption of the new standard will result in expanded revenue disclosures. The Company plans to adopt the new standard which will be effective for the Company beginning in fiscal 2019 using the modified retrospective approach.
Hedges	Hedges In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities in order to more closely align the results of hedge accounting with risk management activities through changes to the designation and measurement guidance. The new standard is effective for interim and annual periods beginning after December 15, 2018. The effect of adoption should be reflected on all active hedges as of the beginning of the fiscal year of adoption. The Company has chosen to early adopt this standard for fiscal 2018, and the adoption of this standard did not have a material impact on the consolidated financial statements.
Comprehensive Income	Comprehensive Income In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income. The new standard allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The new standard is effective for interim and annual periods beginning after December 15, 2018. The Company is currently evaluating the impact of this standard.

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Jun. 30, 2018
Acquisitions [Abstract]
Purchase Price Allocation	The following table summarizes the preliminary purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition: Working capital (a) $ 70 Property and equipment 164 Intangible assets 118 Goodwill 123 Other assets and long-term liabilities (1 ) (a) Includes a $3 million step up of inventory to fair value

Restructuring and Impairment 25

Restructuring and Impairment Charges (Tables)	9 Months Ended
	Jun. 30, 2018
Restructuring and Impairment Charges [Abstract]
Restructuring Charges by Segment	The tables below set forth the significant components of the restructuring charges recognized, by segment: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Engineered Materials $ 2 $ 2 $ 4 $ 4 Health, Hygiene & Specialties 4 4 26 8 Consumer Packaging 1 2 3 6 Consolidated $ 7 $ 8 $ 33 $ 18
Restructuring Accrual Activity	The table below sets forth the activity with respect to the restructuring accrual at June 30, 2018: Employee Severance and Benefits Facility Exit Costs Total Balance at September 30, 2017 $ 14 $ 5 $ 19 Charges 31 2 33 Cash payments (30 ) (3 ) (33 ) Balance at June 30, 2018 $ 15 $ 4 $ 19

Accrued Expenses, Other Curre26

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)	9 Months Ended
	Jun. 30, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Accrued Expenses and Other Current Liabilities	The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets: June 30, 2018 September 30, 2017 Employee compensation $ 109 $ 147 Accrued taxes 73 90 Rebates 54 58 Interest 38 36 Tax receivable agreement obligation 24 35 Restructuring 19 19 Accrued operating expenses 84 78 $ 401 $ 463
Other Long-Term Liabilities	The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets: June 30, 2018 September 30, 2017 Pension liability $ 53 $ 56 Lease retirement obligation 43 37 Deferred purchase price 41 46 Transition tax 36 — Sale-lease back deferred gain 22 24 Derivative instruments 16 27 Tax receivable agreement obligation 13 34 Other 73 76 $ 297 $ 300

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Jun. 30, 2018
Long-Term Debt [Abstract]
Long-Term Debt	Long-term debt consists of the following: Maturity Date June 30, 2018 September 30, 2017 Term loan February 2020 $ 800 $ 1,000 Term loan January 2021 814 814 Term loan October 2022 1,645 1,645 Term loan January 2024 494 498 Revolving line of credit May 2020 — — 5 1 / 2 May 2022 500 500 6% Second Priority Senior Secured Notes October 2022 400 400 5 1 / 8 July 2023 700 700 4 1 / 2 February 2026 500 — Debt discounts and deferred fees (46 ) (48 ) Capital leases and other Various 138 132 Total long-term debt 5,945 5,641 Current portion of long-term debt (35 ) (33 ) Long-term debt, less current portion $ 5,910 $ 5,608

Financial Instruments and Fai28

Financial Instruments and Fair Value Measurements (Tables)	9 Months Ended
	Jun. 30, 2018
Financial Instruments and Fair Value Measurements [Abstract]
Fair Value of Derivatives and Location on Consolidated Balance Sheets	The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. When valuing swaps the Company utilizes Level 2 inputs (substantially observable). Balances on a gross basis as of the current period are as follows: Derivative Instruments Hedge Designation Balance Sheet Location June 30, 2018 September 30, 2017 Cross-currency swaps Designated Other long-term liabilities $ 10 $ — Interest rate swaps Designated Other assets 12 1 Interest rate swaps Not designated Other assets 1 13 Interest rate swaps Designated Other long-term liabilities 4 15 Interest rate swaps Not designated Other long-term liabilities 2 13
Effect of Derivatives on Consolidated Statements of Income	The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Three Quarterly Periods Ended Derivative Instruments Statements of Income Location June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Cross-currency swaps Interest expense, net $ (2 ) $ — $ (4 ) $ — Foreign currency swaps Other expense, net — 1 — — Interest rate swaps Interest expense, net (1 ) 5 2 15
Assets Measured at Fair Value on Non-recurring Basis	Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of June 30, 2018 and September 30, 2017, along with the impairment loss recognized on the fair value measurement during the period: As of June 30, 2018 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 2,880 2,880 — Definite lived intangible assets — — 1,029 1,029 — Property, plant, and equipment — — 2,507 2,507 — Total $ — $ — $ 6,664 $ 6,664 $ — As of September 30, 2017 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 2,775 2,775 — Definite lived intangible assets — — 1,038 1,038 — Property, plant, and equipment — — 2,366 2,366 2 Total $ — $ — $ 6,427 $ 6,427 $ 2

Operating Segments (Tables)

Operating Segments (Tables)	9 Months Ended
	Jun. 30, 2018
Operating Segments [Abstract]
Selected Information by Reportable Segment	Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: Engineered Materials $ 687 $ 686 $ 1,990 $ 1,689 Health, Hygiene & Specialties 726 606 2,009 1,773 Consumer Packaging 659 614 1,816 1,752 Total net sales $ 2,072 $ 1,906 $ 5,815 $ 5,214 Operating income: Engineered Materials $ 94 $ 99 $ 276 $ 219 Health, Hygiene & Specialties 62 53 140 164 Consumer Packaging 60 60 151 150 Total operating income $ 216 $ 212 $ 567 $ 533 Depreciation and amortization: Engineered Materials $ 26 $ 30 $ 82 $ 73 Health, Hygiene & Specialties 51 46 146 136 Consumer Packaging 59 56 169 174 Total depreciation and amortization $ 136 $ 132 $ 397 $ 383 June 30, 2018 September 30, 2017 Total assets: Engineered Materials $ 1,795 $ 1,803 Health, Hygiene & Specialties 3,963 3,496 Consumer Packaging 3,284 3,177 Total assets $ 9,042 $ 8,476 Total goodwill: Engineered Materials $ 550 $ 545 Health, Hygiene & Specialties 921 819 Consumer Packaging 1,409 1,411 Total goodwill $ 2,880 $ 2,775
Selected Information by Geography	Selected information by geographical region is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: North America $ 1,636 $ 1,591 $ 4,703 $ 4,289 South America 193 85 347 246 Europe 181 165 577 482 Asia 62 65 188 197 Total net sales $ 2,072 $ 1,906 $ 5,815 $ 5,214 June 30, 2018 September 30, 2017 Long-lived assets: North America $ 5,598 $ 5,350 South America 343 371 Europe 459 467 Asia 305 284 Total Long-lived assets $ 6,705 $ 6,472
Selected Information by Product Line	Selected information by product line is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended (in percentages) June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Net sales: Performance Materials 46 % 46 % 46 % 46 % Engineered Products 54 54 54 54 Engineered Materials 100 % 100 % 100 % 100 % Health 16 % 22 % 17 % 22 % Hygiene 52 44 48 44 Specialties 32 34 35 34 Health, Hygiene & Specialties 100 % 100 % 100 % 100 % Rigid Open Top 45 % 44 % 43 % 42 % Rigid Closed Top 55 56 57 58 Consumer Packaging 100 % 100 % 100 % 100 %

Basic and Diluted Net Income 30

Basic and Diluted Net Income Per Share (Tables)	9 Months Ended
	Jun. 30, 2018
Basic and Diluted Net Income Per Share [Abstract]
Basic and Diluted Net Income Per Share	The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations. Quarterly Period Ended Three Quarterly Periods Ended (in millions, except per share amounts) June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Numerator Net income $ 110 $ 107 $ 363 $ 230 Denominator Weighted average common shares outstanding - basic 131.7 129.9 131.3 126.6 Dilutive shares 3.7 5.3 4.5 4.8 Weighted average common and common equivalent shares outstanding - diluted 135.4 135.2 135.8 131.4 Per common share income Basic $ 0.84 $ 0.82 $ 2.76 $ 1.82 Diluted $ 0.81 $ 0.79 $ 2.67 $ 1.75

Accumulated Other Comprehensi31

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jun. 30, 2018
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	The components and activity of Accumulated other comprehensive loss are as follows: Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Interest Rate Swaps Accumulated Other Comprehensive Loss Balance at September 30, 2017 $ (48 ) $ (16 ) $ (4 ) $ (68 ) Other comprehensive income (loss) before reclassifications (109 ) (1 ) 42 (68 ) Net amount reclassified from accumulated other comprehensive income (loss) — — 5 5 Provision for income taxes — — (13 ) (13 ) Balance at June 30, 2018 $ (157 ) $ (17 ) $ 30 $ (144 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Interest Rate Swaps Accumulated Other Comprehensive Loss Balance at October 1, 2016 $ (82 ) $ (44 ) $ (22 ) $ (148 ) Other comprehensive income (loss) before reclassifications 4 13 5 22 Net amount reclassified from accumulated other comprehensive income (loss) — — 18 18 Provision for income taxes — — (8 ) (8 ) Balance at July 1, 2017 $ (78 ) $ (31 ) $ (7 ) $ (116 )

Guarantor and Non-Guarantor F32

Guarantor and Non-Guarantor Financial Information (Tables)	9 Months Ended
	Jun. 30, 2018
Guarantor and Non-Guarantor Financial Information [Abstract]
Condensed Supplemental Consolidated Financial Information	Condensed Supplemental Consolidated Balance Sheet June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Current assets $ — $ 311 $ 1,270 $ 756 $ — $ 2,337 Intercompany receivable 332 2,101 — — (2,433 ) — Property, plant, and equipment, net — 79 1,688 740 — 2,507 Other assets 1,378 5,995 4,713 497 (8,385 ) 4,198 Total assets $ 1,710 $ 8,486 $ 7,671 $ 1,993 $ (10,818 ) $ 9,042 Current liabilities $ 24 $ 253 $ 580 $ 305 $ — $ 1,162 Intercompany payable — — 2,373 60 (2,433 ) — Other long-term liabilities 347 6,049 85 60 — 6,541 Stockholders' equity 1,339 2,184 4,633 1,568 (8,385 ) 1,339 Total liabilities and stockholders' equity $ 1,710 $ 8,486 $ 7,671 $ 1,993 $ (10,818 ) $ 9,042 September 30, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Current assets $ — $ 116 $ 1,113 $ 775 $ — $ 2,004 Intercompany receivable 512 2,217 — — (2,729 ) — Property, plant and equipment, net — 80 1,564 722 — 2,366 Other assets 992 5,335 4,583 533 (7,337 ) 4,106 Total assets $ 1,504 $ 7,748 $ 7,260 $ 2,030 $ (10,066 ) $ 8,476 Current liabilities $ 36 $ 243 $ 537 $ 318 $ — $ 1,134 Intercompany payable — — 2,667 62 (2,729 ) — Other long-term liabilities 453 5,707 99 68 — 6,327 Stockholders' equity 1,015 1,798 3,957 1,582 (7,337 ) 1,015 Total liabilities and stockholders' equity $ 1,504 $ 7,748 $ 7,260 $ 2,030 $ (10,066 ) $ 8,476 Condensed Supplemental Consolidated Statements of Income Quarterly Period Ended June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 147 $ 1,452 $ 473 $ — $ 2,072 Cost of goods sold — 121 1,173 396 — 1,690 Selling, general and administrative — 14 70 35 — 119 Amortization of intangibles — — 34 6 — 40 Restructuring and impairment charges — — 4 3 — 7 Operating income — 12 171 33 — 216 Other expense (income), net — — 1 2 — 3 Interest expense, net — 5 46 16 — 67 Equity in net income of subsidiaries (146 ) (128 ) — — 274 — Income before income taxes 146 135 124 15 (274 ) 146 Income tax expense 36 25 3 8 (36 ) 36 Net income $ 110 $ 110 $ 121 $ 7 $ (238 ) $ 110 Comprehensive net income $ 110 $ 133 $ 121 $ (104 ) $ (238 ) $ 22 Quarterly Period Ended July 1, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 152 $ 1,325 $ 429 $ — $ 1,906 Cost of goods sold — 100 1,059 359 — 1,518 Selling, general and administrative — 14 89 25 — 128 Amortization of intangibles — 2 31 7 — 40 Restructuring and impairment charges — — - 8 — 8 Operating income — 36 146 30 — 212 Other expense (income), net — 1 (1 ) (1 ) — (1 ) Interest expense, net — 5 47 16 — 68 Equity in net income of subsidiaries (145 ) (109 ) — — 254 — Income before income taxes 145 139 100 15 (254 ) 145 Income tax expense 38 32 — 6 (38 ) 38 Net income $ 107 $ 107 $ 100 $ 9 $ (216 ) $ 107 Comprehensive net income $ 107 $ 102 $ 100 $ 37 $ (216 ) $ 130 Three Quarterly Periods Ended June 30, 2018 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 424 $ 4,026 $ 1,365 $ — $ 5,815 Cost of goods sold — 322 3,265 1,146 — 4,733 Selling, general and administrative — 44 233 89 — 366 Amortization of intangibles — — 96 20 — 116 Restructuring and impairment charges — — 20 13 — 33 Operating income — 58 412 97 — 567 Other expense (income), net — 5 8 4 — 17 Interest expense, net — 14 134 47 — 195 Equity in net income of subsidiaries (355 ) (287 ) — — 642 — Income before income taxes 355 326 270 46 (642 ) 355 Income tax expense (8 ) (37 ) 4 25 8 (8 ) Net income $ 363 $ 363 $ 266 $ 21 $ (650 ) $ 363 Comprehensive net income $ 363 $ 387 $ 266 $ (79 ) $ (650 ) $ 287 Consolidating Statement of Cash Flows Cash Flow from Operating Activities $ — $ 29 $ 480 $ 47 $ — $ 556 Cash Flow from Investing Activities Additions to property, plant, and equipment — (5 ) (194 ) (71 ) — (270 ) Proceeds from sale of assets — — — 3 — 3 Contributions (to)/from subsidiaries (17 ) (457 ) — — 474 — Intercompany — 314 — — (314 ) — Acquisition of business, net of cash acquired — — (404 ) (70 ) — (474 ) Other investing activities, net — — — — — — Net cash from investing activities (17 ) (148 ) (598 ) (138 ) 160 (741 ) Cash Flow from Financing Activities Proceeds from long-term debt — 497 — — — 497 Repayments on long-term borrowings — (219 ) (5 ) — — (224 ) Proceeds from issuance of common stock 17 — — — — 17 Payment of tax receivable agreement (37 ) — — — — (37 ) Contribution from Parent — — 404 70 (474 ) — Debt financing costs — (1 ) — — — (1 ) Changes in intercompany balances 37 — (291 ) (60 ) 314 — Net cash from financing activities 17 277 108 10 (160 ) 252 Effect of exchange rate changes on cash — — — (8 ) — (8 ) Net change in cash — 158 (10 ) (89 ) — 59 Cash and cash equivalents at beginning of period — 18 12 276 — 306 Cash and cash equivalents at end of period $ — $ 176 $ 2 $ 187 $ — $ 365 Three Quarterly Periods Ended July 1, 2017 Parent Issuer Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Total Net sales $ — $ 441 $ 3,556 $ 1,217 $ — $ 5,214 Cost of goods sold — 333 2,860 984 — 4,177 Selling, general and administrative — 45 251 77 — 373 Amortization of intangibles — 5 87 21 — 113 Restructuring and impairment charges — — 10 8 — 18 Operating income — 58 348 127 — 533 Other expense (income), net — 15 1 2 — 18 Interest expense, net — 17 138 48 — 203 Equity in net income of subsidiaries (312 ) (252 ) — — 564 — Income before income taxes 312 278 209 77 (564 ) 312 Income tax expense 82 48 — 34 (82 ) 82 Net income $ 230 $ 230 $ 209 $ 43 $ (482 ) $ 230 Comprehensive net income $ 230 $ 245 $ 209 $ 60 $ (482 ) $ 262 Consolidating Statement of Cash Flows Cash Flow from Operating Activities $ — $ 31 $ 420 $ 129 $ — $ 580 Cash Flow from Investing Activities Additions to property, plant, and equipment — (11 ) (160 ) (30 ) — (201 ) Proceeds from sale of assets — 1 3 — — 4 Contributions (to)/from subsidiaries (26 ) (489 ) — — 515 — Intercompany — 280 — — (280 ) — Acquisition of business, net of cash acquired — — (515 ) — — (515 ) Other investing activities, net — (1 ) — — — (1 ) Net cash from investing activities (26 ) (220 ) (672 ) (30 ) 235 (713 ) Cash Flow from Financing Activities Proceeds from long-term debt — 545 — — — 545 Repayments on long-term borrowings — (423 ) (3 ) (1 ) — (427 ) Proceeds from issuance of common stock 26 — — — — 26 Payment of tax receivable agreement (60 ) — — — — (60 ) Debt financing costs — (4 ) — — — (4 ) Contribution from parent — — 515 — (515 ) — Changes in intercompany balances 60 — (255 ) (85 ) 280 — Net cash from financing activities 26 118 257 (86 ) (235 ) 80 Effect of exchange rate changes on cash — — — 5 — 5 Net change in cash — (71 ) 5 18 — (48 ) Cash and cash equivalents at beginning of period — 102 5 216 — 323 Cash and cash equivalents at end of period $ — $ 31 $ 10 $ 234 $ — $ 275

Acquisitions, AEP Industries In

Acquisitions, AEP Industries Inc. (Details) - AEP [Member] - USD ($) shares in Millions, $ in Millions	1 Months Ended	9 Months Ended
	Jan. 31, 2017	Jul. 01, 2017
Acquisition [Abstract]
Purchase price, net of cash acquired	$ 791
Number of shares issued (in shares)	6.4
Value of shares issued at time of closing	$ 324
Pro Forma Information [Abstract]
Pro forma net sales		$ 5,500
Pro forma net income		$ 232
Term Loan due January 2024 [Member]
Acquisition [Abstract]
Face amount of debt issued	$ 500

Acquisitions, Adchem Corp (Deta

Acquisitions, Adchem Corp (Details) $ in Millions	1 Months Ended
	Jun. 30, 2017USD ($)
Adchem [Member]
Acquisition [Abstract]
Purchase price	$ 49

Acquisitions, Clopay Plastic Pr

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($) $ in Millions		Feb. 28, 2018	Jun. 30, 2018	Jan. 31, 2018	Sep. 30, 2017
Allocation of Purchase Price [Abstract]
Goodwill			$ 2,880		$ 2,775
4.50% Second Priority Senior Secured Notes due 2026 [Member]
Acquisition [Abstract]
Face amount of debt issued				$ 500
Interest rate				4.50%
Clopay [Member]
Acquisition [Abstract]
Purchase price		$ 474
Allocation of Purchase Price [Abstract]
Working capital	[1]	70
Property and equipment		164
Intangible assets		118
Goodwill		123
Other assets and long-term liabilities		(1)
Step up of inventory to fair value		$ 3
[1]	Includes a $3 million step up of inventory to fair value.

Accounts Receivable Factoring36

Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 108	$ 129

Restructuring and Impairment 37

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Restructuring Charges [Abstract]
Restructuring charges	$ 7	$ 8	$ 33	$ 18
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	2	2	4	4
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	4	4	26	8
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 1	$ 2	$ 3	$ 6

Restructuring and Impairment 38

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Restructuring Accrual [Roll Forward]
Beginning balance			$ 19
Charges	$ 7	$ 8	33	$ 18
Cash payments			(33)
Ending balance	19		19
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			14
Charges			31
Cash payments			(30)
Ending balance	15		15
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			5
Charges			2
Cash payments			(3)
Ending balance	$ 4		$ 4

Accrued Expenses, Other Curre39

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation	$ 109	$ 147
Accrued taxes	73	90
Rebates	54	58
Interest	38	36
Tax receivable agreement obligation	24	35
Restructuring	19	19
Accrued operating expenses	84	78
Accrued expenses and other current liabilities	$ 401	$ 463

Accrued Expenses, Other Curre40

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Pension liability	$ 53	$ 56
Lease retirement obligation	43	37
Deferred purchase price	41	46
Transition tax	36	0
Sale-lease back deferred gain	22	24
Derivative instruments	16	27
Tax receivable agreement obligation	13	34
Other	73	76
Other long-term liabilities	$ 297	$ 300

Long-Term Debt, Summary of Long

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jan. 31, 2018	Sep. 30, 2017
Long-term Debt [Abstract]
Debt discounts and deferred fees	$ (46)		$ (48)
Capital leases and other	138		132
Total long-term debt	5,945		5,641
Current portion of long-term debt	(35)		(33)
Long-term debt, less current portion	5,910		5,608
Term Loan due February 2020 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 800		1,000
Maturity date	Feb. 29, 2020
Term Loan due January 2021 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 814		814
Maturity date	Jan. 31, 2021
Term Loan due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,645		1,645
Maturity date	Oct. 31, 2022
Term Loan due January 2024 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 494		498
Maturity date	Jan. 31, 2024
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt	$ 0		0
Maturity date	May 31, 2020
5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500		500
Interest rate	5.50%
Maturity date	May 31, 2022
6% Second Priority Senior Secured Notes due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 400		400
Interest rate	6.00%
Maturity date	Oct. 31, 2022
5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700		700
Interest rate	5.125%
Maturity date	Jul. 31, 2023
4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500		$ 0
Interest rate	4.50%	4.50%
Maturity date	Feb. 28, 2026

Long-Term Debt, 4.50% Second Pr

Long-Term Debt, 4.50% Second Priority Senior Secured Notes (Details) - 4 1/2% Second Priority Senior Secured Notes due February 2026 [Member] - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jan. 31, 2018
Long-Term Debt [Abstract]
Face amount of debt issued		$ 500
Interest rate	4.50%	4.50%
Maturity date	Feb. 28, 2026
Debt discount		$ 4

Long-Term Debt, Term Loans (Det

Long-Term Debt, Term Loans (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Jul. 01, 2017
Long-Term Debt [Abstract]
Repayments on long-term debt		$ 224	$ 427
Term Loan due February 2020 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due January 2021 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due October 2022 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%
Term Loan due January 2024 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%

Financial Instruments and Fai44

Financial Instruments and Fair Value Measurements, Cross-Currency and Interest Rate Swaps (Details) € in Millions, $ in Millions	1 Months Ended		9 Months Ended
	Jun. 30, 2018USD ($)Instrument	Jun. 28, 2013USD ($)	Jun. 30, 2018USD ($)	Nov. 30, 2017EUR (€)	Feb. 28, 2013USD ($)
Cross-Currency and Interest Rate Swaps [Abstract]
Number of derivative instruments settled | Instrument	2
Cross-Currency Swaps [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap | €				€ 250
Interest Rate Swap - February 2013 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap					$ 1,000
Cash received for settlement of derivative contract		$ 16
Interest Rate Swap - March 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Cash received for settlement of derivative contract	$ 9
Interest Rate Swap - February 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Cash received for settlement of derivative contract	21
Interest Rate Swap - May 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 450		$ 450
Fixed annual rate of swap	2.00%		2.00%
Interest Rate Swap - May 2017 [Member] | LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate			1 month
Interest Rate Swap - June 2018 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 1,000		$ 1,000
Fixed annual rate of swap	2.808%		2.808%
Interest Rate Swap - June 2018 [Member] | LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate			1 month

Financial Instruments and Fai45

Financial Instruments and Fair Value Measurements, Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Cross-Currency Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 10	$ 0
Interest Rate Swaps [Member] | Designated [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	12	1
Interest Rate Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	4	15
Interest Rate Swaps [Member] | Not Designated [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	1	13
Interest Rate Swaps [Member] | Not Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 2	$ 13

Financial Instruments and Fai46

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Derivative Instruments [Abstract]
Amortization related to unrealized losses in Accumulated other comprehensive loss for next 12 months			$ 13
Cross-Currency Swaps [Member] | Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Gain (loss) on derivative instruments	$ (2)	$ 0	(4)	$ 0
Foreign Currency Swaps [Member] | Other Expense, Net [Member]
Derivative Instruments [Abstract]
Gain (loss) on derivative instruments	0	1	0	0
Interest Rate Swaps [Member] | Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Gain (loss) on derivative instruments	$ (1)	$ 5	$ 2	$ 15

Financial Instruments and Fai47

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Jun. 30, 2018	Sep. 30, 2017
Non-recurring Fair Value Measurements [Abstract]
Goodwill	$ 2,880	$ 2,775
Impairment [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	2
Impairment charges	0	2
Fair Value Adjustment [Abstract]
Book value of long-term indebtedness in excess of fair value	$ 22
Health, Hygiene & Specialties [Member] | South America [Member]
Non-recurring Fair Value Measurements [Abstract]
Percentage of fair value in excess of carrying value	5.00%
Goodwill	$ 92
Market Approach and Discounted Cash Flow Analysis [Member] | Overall Revenue Growth Rate [Member] | Health, Hygiene & Specialties [Member] | South America [Member]
Non-recurring Fair Value Measurements [Abstract]
Reporting unit, Measurement input	0.02
Market Approach and Discounted Cash Flow Analysis [Member] | Overall Revenue Growth Rate [Member] | Maximum [Member] | Health, Hygiene & Specialties [Member] | South America [Member]
Non-recurring Fair Value Measurements [Abstract]
Reporting unit, Measurement input	0.04
Market Approach and Discounted Cash Flow Analysis [Member] | Discount Rate [Member] | Health, Hygiene & Specialties [Member] | South America [Member]
Non-recurring Fair Value Measurements [Abstract]
Reporting unit, Measurement input	0.14
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	$ 248	248
Goodwill	2,880	2,775
Definite lived intangible assets	1,029	1,038
Property, plant, and equipment	2,507	2,366
Total	6,664	6,427
Fair Value on Nonrecurring Basis [Member] | Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	2,880	2,775
Definite lived intangible assets	1,029	1,038
Property, plant, and equipment	2,507	2,366
Total	$ 6,664	$ 6,427

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Dec. 30, 2017	Jun. 30, 2018
Income Taxes [Abstract]
U. S. corporate income tax rate			21.00%
Provisional transition tax benefit		$ (95)
Repatriation tax charge		44
Net deferred tax revaluation benefit		$ (139)
Effective tax rate	25.00%
Share-based compensation excess tax benefit	(1.00%)
Research and development credits	(1.00%)
Domestic manufacturing tax benefit	(2.00%)
U.S. state income taxes	3.00%
Foreign valuation allowance	2.00%

Operating Segments, Selected In

Operating Segments, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018USD ($)	Jul. 01, 2017USD ($)	Jun. 30, 2018USD ($)Segment	Jul. 01, 2017USD ($)	Sep. 30, 2017USD ($)
Selected Information by Reportable Segment [Abstract]
Number of reporting segments | Segment			3
Net sales	$ 2,072	$ 1,906	$ 5,815	$ 5,214
Operating income	216	212	567	533
Depreciation and amortization	136	132	397	383
Total assets	9,042		9,042		$ 8,476
Total goodwill	2,880		2,880		2,775
Operating Segment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	687	686	1,990	1,689
Operating income	94	99	276	219
Depreciation and amortization	26	30	82	73
Total assets	1,795		1,795		1,803
Total goodwill	550		550		545
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	726	606	2,009	1,773
Operating income	62	53	140	164
Depreciation and amortization	51	46	146	136
Total assets	3,963		3,963		3,496
Total goodwill	921		921		819
Operating Segment [Member] | Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	659	614	1,816	1,752
Operating income	60	60	151	150
Depreciation and amortization	59	$ 56	169	$ 174
Total assets	3,284		3,284		3,177
Total goodwill	$ 1,409		$ 1,409		$ 1,411

Operating Segments, Selected 50

Operating Segments, Selected Information by Geography (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017	Sep. 30, 2017
Selected Information by Geography [Abstract]
Net sales	$ 2,072	$ 1,906	$ 5,815	$ 5,214
Long-lived assets	6,705		6,705		$ 6,472
Reportable Geography [Member] | North America [Member]
Selected Information by Geography [Abstract]
Net sales	1,636	1,591	4,703	4,289
Long-lived assets	5,598		5,598		5,350
Reportable Geography [Member] | South America [Member]
Selected Information by Geography [Abstract]
Net sales	193	85	347	246
Long-lived assets	343		343		371
Reportable Geography [Member] | Europe [Member]
Selected Information by Geography [Abstract]
Net sales	181	165	577	482
Long-lived assets	459		459		467
Reportable Geography [Member] | Asia [Member]
Selected Information by Geography [Abstract]
Net sales	62	$ 65	188	$ 197
Long-lived assets	$ 305		$ 305		$ 284

Operating Segments, Selected 51

Operating Segments, Selected Information by Product Line (Details) - Net Sales [Member]	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Engineered Materials [Member] | Performance Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	46.00%	46.00%	46.00%	46.00%
Engineered Materials [Member] | Engineered Products [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	54.00%	54.00%	54.00%	54.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Health, Hygiene & Specialties [Member] | Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	16.00%	22.00%	17.00%	22.00%
Health, Hygiene & Specialties [Member] | Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	52.00%	44.00%	48.00%	44.00%
Health, Hygiene & Specialties [Member] | Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	32.00%	34.00%	35.00%	34.00%
Consumer Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Consumer Packaging [Member] | Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	45.00%	44.00%	43.00%	42.00%
Consumer Packaging [Member] | Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	55.00%	56.00%	57.00%	58.00%

Basic and Diluted Net Income 52

Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Basic and Diluted Net Income Per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	0		0
Numerator [Abstract]
Net income	$ 110	$ 107	$ 363	$ 230
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	131.7	129.9	131.3	126.6
Dilutive shares (in shares)	3.7	5.3	4.5	4.8
Weighted average common and common equivalent shares outstanding - diluted (in shares)	135.4	135.2	135.8	131.4
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 0.84	$ 0.82	$ 2.76	$ 1.82
Diluted (in dollars per share)	$ 0.81	$ 0.79	$ 2.67	$ 1.75

Accumulated Other Comprehensi53

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Accumulated Other Comprehensive Loss [Roll Forward]
Other comprehensive income (loss) before reclassifications			$ (68)	$ 22
Net amount reclassified from accumulated other comprehensive income (loss)			5	18
Provision for income taxes	$ (2)	$ 0	(13)	(8)
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			(68)	(148)
Ending balance	(144)	(116)	(144)	(116)
Currency Translation [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			(48)	(82)
Other comprehensive income (loss) before reclassifications			(109)	4
Net amount reclassified from accumulated other comprehensive income (loss)			0	0
Provision for income taxes			0	0
Ending balance	(157)	(78)	(157)	(78)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			(16)	(44)
Other comprehensive income (loss) before reclassifications			(1)	13
Net amount reclassified from accumulated other comprehensive income (loss)			0	0
Provision for income taxes			0	0
Ending balance	(17)	(31)	(17)	(31)
Interest Rate Swaps [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			(4)	(22)
Other comprehensive income (loss) before reclassifications			42	5
Net amount reclassified from accumulated other comprehensive income (loss)			5	18
Provision for income taxes			(13)	(8)
Ending balance	$ 30	$ (7)	$ 30	$ (7)

Guarantor and Non-Guarantor F54

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Balance Sheet (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Sep. 30, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Percentage ownership in guarantor subsidiaries	100.00%
Assets [Abstract]
Current assets	$ 2,337	$ 2,004
Intercompany receivable	0	0
Property, plant, and equipment, net	2,507	2,366
Other assets	4,198	4,106
Total assets	9,042	8,476
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	1,162	1,134
Intercompany payable	0	0
Other long-term liabilities	6,541	6,327
Stockholders' equity	1,339	1,015
Total liabilities and stockholders' equity	9,042	8,476
Eliminations [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	(2,433)	(2,729)
Property, plant, and equipment, net	0	0
Other assets	(8,385)	(7,337)
Total assets	(10,818)	(10,066)
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	0	0
Intercompany payable	(2,433)	(2,729)
Other long-term liabilities	0	0
Stockholders' equity	(8,385)	(7,337)
Total liabilities and stockholders' equity	(10,818)	(10,066)
Parent [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	332	512
Property, plant, and equipment, net	0	0
Other assets	1,378	992
Total assets	1,710	1,504
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	24	36
Intercompany payable	0	0
Other long-term liabilities	347	453
Stockholders' equity	1,339	1,015
Total liabilities and stockholders' equity	1,710	1,504
Issuer [Member]
Assets [Abstract]
Current assets	311	116
Intercompany receivable	2,101	2,217
Property, plant, and equipment, net	79	80
Other assets	5,995	5,335
Total assets	8,486	7,748
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	253	243
Intercompany payable	0	0
Other long-term liabilities	6,049	5,707
Stockholders' equity	2,184	1,798
Total liabilities and stockholders' equity	8,486	7,748
Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	1,270	1,113
Intercompany receivable	0	0
Property, plant, and equipment, net	1,688	1,564
Other assets	4,713	4,583
Total assets	7,671	7,260
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	580	537
Intercompany payable	2,373	2,667
Other long-term liabilities	85	99
Stockholders' equity	4,633	3,957
Total liabilities and stockholders' equity	7,671	7,260
Non-Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	756	775
Intercompany receivable	0	0
Property, plant, and equipment, net	740	722
Other assets	497	533
Total assets	1,993	2,030
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	305	318
Intercompany payable	60	62
Other long-term liabilities	60	68
Stockholders' equity	1,568	1,582
Total liabilities and stockholders' equity	$ 1,993	$ 2,030

Guarantor and Non-Guarantor F55

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jun. 30, 2018	Jul. 01, 2017
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	$ 2,072	$ 1,906	$ 5,815	$ 5,214
Cost of goods sold	1,690	1,518	4,733	4,177
Selling, general and administrative	119	128	366	373
Amortization of intangibles	40	40	116	113
Restructuring and impairment charges	7	8	33	18
Operating income	216	212	567	533
Other expense (income), net	3	(1)	17	18
Interest expense, net	67	68	195	203
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	146	145	355	312
Income tax expense	36	38	(8)	82
Net income	110	107	363	230
Comprehensive net income	22	130	287	262
Eliminations [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0	0	0
Cost of goods sold	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of intangibles	0	0	0	0
Restructuring and impairment charges	0	0	0	0
Operating income	0	0	0	0
Other expense (income), net	0	0	0	0
Interest expense, net	0	0	0	0
Equity in net income of subsidiaries	274	254	642	564
Income before income taxes	(274)	(254)	(642)	(564)
Income tax expense	(36)	(38)	8	(82)
Net income	(238)	(216)	(650)	(482)
Comprehensive net income	(238)	(216)	(650)	(482)
Parent [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0	0	0
Cost of goods sold	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of intangibles	0	0	0	0
Restructuring and impairment charges	0	0	0	0
Operating income	0	0	0	0
Other expense (income), net	0	0	0	0
Interest expense, net	0	0	0	0
Equity in net income of subsidiaries	(146)	(145)	(355)	(312)
Income before income taxes	146	145	355	312
Income tax expense	36	38	(8)	82
Net income	110	107	363	230
Comprehensive net income	110	107	363	230
Issuer [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	147	152	424	441
Cost of goods sold	121	100	322	333
Selling, general and administrative	14	14	44	45
Amortization of intangibles	0	2	0	5
Restructuring and impairment charges	0	0	0	0
Operating income	12	36	58	58
Other expense (income), net	0	1	5	15
Interest expense, net	5	5	14	17
Equity in net income of subsidiaries	(128)	(109)	(287)	(252)
Income before income taxes	135	139	326	278
Income tax expense	25	32	(37)	48
Net income	110	107	363	230
Comprehensive net income	133	102	387	245
Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	1,452	1,325	4,026	3,556
Cost of goods sold	1,173	1,059	3,265	2,860
Selling, general and administrative	70	89	233	251
Amortization of intangibles	34	31	96	87
Restructuring and impairment charges	4	0	20	10
Operating income	171	146	412	348
Other expense (income), net	1	(1)	8	1
Interest expense, net	46	47	134	138
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	124	100	270	209
Income tax expense	3	0	4	0
Net income	121	100	266	209
Comprehensive net income	121	100	266	209
Non-Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	473	429	1,365	1,217
Cost of goods sold	396	359	1,146	984
Selling, general and administrative	35	25	89	77
Amortization of intangibles	6	7	20	21
Restructuring and impairment charges	3	8	13	8
Operating income	33	30	97	127
Other expense (income), net	2	(1)	4	2
Interest expense, net	16	16	47	48
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	15	15	46	77
Income tax expense	8	6	25	34
Net income	7	9	21	43
Comprehensive net income	$ (104)	$ 37	$ (79)	$ 60

Guarantor and Non-Guarantor F56

Guarantor and Non-Guarantor Financial Information, Consolidating Statement of Cash Flows (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jul. 01, 2017
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	$ 556	$ 580
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(270)	(201)
Proceeds from sale of assets	3	4
Contributions (to)/from subsidiaries	0	0
Intercompany	0	0
Acquisition of business, net of cash acquired	(474)	(515)
Other investing activities, net	0	(1)
Net cash from investing activities	(741)	(713)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	497	545
Repayments on long-term borrowings	(224)	(427)
Proceeds from issuance of common stock	17	26
Payment of tax receivable agreement	(37)	(60)
Contribution from Parent	0	0
Debt financing costs	(1)	(4)
Changes in intercompany balances	0	0
Net cash from financing activities	252	80
Effect of exchange rate changes on cash	(8)	5
Net change in cash	59	(48)
Cash and cash equivalents at beginning of period	306	323
Cash and cash equivalents at end of period	365	275
Eliminations [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
Contributions (to)/from subsidiaries	474	515
Intercompany	(314)	(280)
Acquisition of business, net of cash acquired	0	0
Other investing activities, net	0	0
Net cash from investing activities	160	235
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	0	0
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	0	0
Payment of tax receivable agreement	0	0
Contribution from Parent	(474)	(515)
Debt financing costs	0	0
Changes in intercompany balances	314	280
Net cash from financing activities	(160)	(235)
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Parent [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
Contributions (to)/from subsidiaries	(17)	(26)
Intercompany	0	0
Acquisition of business, net of cash acquired	0	0
Other investing activities, net	0	0
Net cash from investing activities	(17)	(26)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	0	0
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	17	26
Payment of tax receivable agreement	(37)	(60)
Contribution from Parent	0	0
Debt financing costs	0	0
Changes in intercompany balances	37	60
Net cash from financing activities	17	26
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Issuer [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	29	31
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(5)	(11)
Proceeds from sale of assets	0	1
Contributions (to)/from subsidiaries	(457)	(489)
Intercompany	314	280
Acquisition of business, net of cash acquired	0	0
Other investing activities, net	0	(1)
Net cash from investing activities	(148)	(220)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	497	545
Repayments on long-term borrowings	(219)	(423)
Proceeds from issuance of common stock	0	0
Payment of tax receivable agreement	0	0
Contribution from Parent	0	0
Debt financing costs	(1)	(4)
Changes in intercompany balances	0	0
Net cash from financing activities	277	118
Effect of exchange rate changes on cash	0	0
Net change in cash	158	(71)
Cash and cash equivalents at beginning of period	18	102
Cash and cash equivalents at end of period	176	31
Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	480	420
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(194)	(160)
Proceeds from sale of assets	0	3
Contributions (to)/from subsidiaries	0	0
Intercompany	0	0
Acquisition of business, net of cash acquired	(404)	(515)
Other investing activities, net	0	0
Net cash from investing activities	(598)	(672)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	0	0
Repayments on long-term borrowings	(5)	(3)
Proceeds from issuance of common stock	0	0
Payment of tax receivable agreement	0	0
Contribution from Parent	404	515
Debt financing costs	0	0
Changes in intercompany balances	(291)	(255)
Net cash from financing activities	108	257
Effect of exchange rate changes on cash	0	0
Net change in cash	(10)	5
Cash and cash equivalents at beginning of period	12	5
Cash and cash equivalents at end of period	2	10
Non-Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash Flow from Operating Activities	47	129
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(71)	(30)
Proceeds from sale of assets	3	0
Contributions (to)/from subsidiaries	0	0
Intercompany	0	0
Acquisition of business, net of cash acquired	(70)	0
Other investing activities, net	0	0
Net cash from investing activities	(138)	(30)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term debt	0	0
Repayments on long-term borrowings	0	(1)
Proceeds from issuance of common stock	0	0
Payment of tax receivable agreement	0	0
Contribution from Parent	70	0
Debt financing costs	0	0
Changes in intercompany balances	(60)	(85)
Net cash from financing activities	10	(86)
Effect of exchange rate changes on cash	(8)	5
Net change in cash	(89)	18
Cash and cash equivalents at beginning of period	276	216
Cash and cash equivalents at end of period	$ 187	$ 234

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Aug. 03, 2018USD ($)
Subsequent Event [Member]
Subsequent Events [Abstract]
Authorized amount of share repurchase program	$ 500